In individuals with seropositive arthralgia, the risk of developing rheumatoid arthritis (RA) rose in the presence of high titers of anti–citrullinated peptide antibodies (ACPAs) and immunoglobulin ...
AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results